Article Versions Notes

Narożna M, Krajka-Kuźniak V, Bednarczyk-Cwynar B, Kucińska M, Kleszcz R, Kujawski J, Piotrowska-Kempisty H, Plewiński A, Murias M, Baer-Dubowska W. Conjugation of Diclofenac with Novel Oleanolic Acid Derivatives Modulate Nrf2 and NF-κB Activity in Hepatic Cancer Cells and Normal Hepatocytes Leading to Enhancement of Its Therapeutic and Chemopreventive Potential. Pharmaceuticals. 2021; 14(7):688. https://doi.org/10.3390/ph14070688

Narożna, Maria, Violetta Krajka-Kuźniak, Barbara Bednarczyk-Cwynar, Małgorzata Kucińska, Robert Kleszcz, Jacek Kujawski, Hanna Piotrowska-Kempisty, Adam Plewiński, Marek Murias, and Wanda Baer-Dubowska. 2021. "Conjugation of Diclofenac with Novel Oleanolic Acid Derivatives Modulate Nrf2 and NF-κB Activity in Hepatic Cancer Cells and Normal Hepatocytes Leading to Enhancement of Its Therapeutic and Chemopreventive Potential" Pharmaceuticals 14, no. 7: 688. https://doi.org/10.3390/ph14070688

Narożna, M., Krajka-Kuźniak, V., Bednarczyk-Cwynar, B., Kucińska, M., Kleszcz, R., Kujawski, J., Piotrowska-Kempisty, H., Plewiński, A., Murias, M., & Baer-Dubowska, W. (2021). Conjugation of Diclofenac with Novel Oleanolic Acid Derivatives Modulate Nrf2 and NF-κB Activity in Hepatic Cancer Cells and Normal Hepatocytes Leading to Enhancement of Its Therapeutic and Chemopreventive Potential. Pharmaceuticals, 14(7), 688. https://doi.org/10.3390/ph14070688